rather than aluminium-containing oral phosphate binders. Limited evidence suggests that aluminium bone disease may also be on the decline in the era of aluminium removal from dialysis fluid ...

Starting Jan. 1, Medicare rolled payments for seven different oral-only phosphate binders into its End Stage Renal Disease Prospective Payment System, a bundle in place since 2011. Most affected ...

Unicycive Therapeutics (UNCY) announced the publication of preclinical data describing the benefits of combination treatment of oxylanthanum ...

Kidney stones are pebble-sized deposits that form when there’s too much salt and minerals in your urine. Learn whether men or women are more at risk, what passing one feels like, and how big ...

Fibrosis has a key role in the progression of kidney disease and kidney failure. Here, the authors examine current options for targeting pro-fibrotic pathways, including the anti-fibrotic ...

Company achieved significant commercial progress in 2024, finishing with total revenue of $333.6 million, including $319.2 million in U.S. Net ...

Hypophosphatemia associated with primary hyperparathyroidism is usually of moderate severity; increased urinary phosphate excretion ... respiratory failure and left ventricular dysfunction ...

Aviceda Therapeutics has got biotech financing in 2025 off to a flying start by raising $207.5 million to take its lead drug for sight-robbing disease ... iron-based phosphate binder AP301 ...

June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an ... Major Cause of Inflammatory ...

Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...